IDEXX Laboratories, Inc. (IDXX)
513.27
-8.75
(-1.68%)
USD |
NASDAQ |
Sep 24, 16:00
513.40
+0.13
(+0.03%)
After-Hours: 19:59
IDEXX Laboratories Enterprise Value : 42.07B for Sept. 23, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| September 23, 2026 | 42.07B |
| September 22, 2026 | 42.03B |
| September 21, 2026 | 41.54B |
| September 18, 2026 | 41.26B |
| September 17, 2026 | 40.85B |
| September 16, 2026 | 41.41B |
| September 15, 2026 | 41.18B |
| September 14, 2026 | 41.09B |
| September 11, 2026 | 40.71B |
| September 10, 2026 | 40.85B |
| September 09, 2026 | 41.53B |
| September 08, 2026 | 41.93B |
| September 04, 2026 | 43.13B |
| September 03, 2026 | 42.65B |
| September 02, 2026 | 43.41B |
| September 01, 2026 | 43.90B |
| August 31, 2026 | 44.81B |
| August 28, 2026 | 44.67B |
| August 27, 2026 | 43.89B |
| August 26, 2026 | 44.55B |
| August 25, 2026 | 44.28B |
| August 24, 2026 | 45.03B |
| August 21, 2026 | 44.83B |
| August 20, 2026 | 43.95B |
| August 19, 2026 | 45.24B |
| Date | Value |
|---|---|
| August 18, 2026 | 44.54B |
| August 17, 2026 | 43.97B |
| August 14, 2026 | 44.36B |
| August 13, 2026 | 45.62B |
| August 12, 2026 | 45.90B |
| August 11, 2026 | 47.17B |
| August 10, 2026 | 47.89B |
| August 07, 2026 | 47.17B |
| August 06, 2026 | 47.43B |
| August 05, 2026 | 47.02B |
| August 04, 2026 | 47.28B |
| August 03, 2026 | 45.69B |
| July 31, 2026 | 45.00B |
| July 30, 2026 | 44.97B |
| July 29, 2026 | 45.84B |
| July 28, 2026 | 45.82B |
| July 27, 2026 | 44.77B |
| July 24, 2026 | 43.83B |
| July 23, 2026 | 43.44B |
| July 22, 2026 | 43.89B |
| July 21, 2026 | 44.47B |
| July 20, 2026 | 45.37B |
| July 17, 2026 | 45.66B |
| July 16, 2026 | 46.34B |
| July 15, 2026 | 44.83B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Intuitive Surgical, Inc. | 135.84B |
| Abbott Laboratories | 206.73B |
| Align Technology, Inc. | 9.575B |
| DexCom, Inc. | 32.56B |
| Integra LifeSciences Holdings Corp. | 2.983B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 338.41M |
| Revenue (Quarterly) | 1.217B |
| Total Expenses (Quarterly) | 878.17M |
| EPS Diluted (Quarterly) | 4.267 |
| Gross Profit Margin (Quarterly) | 64.07% |
| Profit Margin (Quarterly) | 27.82% |
| Earnings Yield | 2.77% |
| Operating Earnings Yield | 3.55% |
| Normalized Earnings Yield | 2.763 |